Second, although we demonstrated that knockdown of CARMN resulted in significant downregulation of CSNK1A1 in vivo, we did not directly validate the biological role of CSNK1A1 in atherosclerosis. This evidence concerns the gene CSNK1A1 and atherosclerosis.